Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities

European Journal of Biochemistry

Volumn 270, Issue 18, 2003, Pages 3739-3749

  Van Den Steen, Philippe E ^a   Wuyts, Anja ^a   Husson, Steven J ^a   Proost, Paul ^a   Van Damme, Jo ^a   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

CXC chemokine; Feedback; Interleukin 8; Mass spectrometry; Neutrophil

Indexed keywords

EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GELATINASE B; INTERLEUKIN 8; NEUTROPHIL COLLAGENASE; NITROGEN;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; GRANULE CELL; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; CALCIUM; CELL DEGRANULATION; CHEMOKINES, CXC; ENZYME ACTIVATION; HUMANS; INTERLEUKIN-8; KINETICS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MICE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHENYLMERCURIC ACETATE; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

ENA;

EID: 0141782259     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2003.03760.x     Document Type: Article

References (57)

1. Opdenakker, G., Van den Steen, P.E., Dubois, B., Nelissen, I., Van Coillie, E., Masure, S., Proost, P. & Van Damme, J. (2001) Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukoc. Biol. 69, 851-859.
2. Schönbeck, U., Mach, F. & Libby, P. (1998) Generation of biologically active IL-1β by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1β processing. J. Immunol. 161, 3340-3346.
3. Van den Steen, P.E., Proost, P., Wuyts, A., Van Damme, J. & Opdenakker, G. (2000) Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96, 2673-2681.
4. McQuibban, G.A., Gong, J.H., Tam, E.M., McCulloch, C.A., Clark-Lewis, I. & Overall, C.M. (2000) Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289, 1202-1206.
5. Rollins, B.J. (1997) Chemokines. Blood 90, 909-928.
6. Wuyts, A., Proost, P. & Van Damme, J. (1998) Interleukin-8 and other CXC chemokines. In The Cytokine Handbook (Thomson, A., ed.), pp. 271-311. Academic Press, London.
7. Strieter, R.M., Polverini, P.J., Kunkel, S.L., Arenberg, D.A., Burdick, M.D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A. & Marriott, D. (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270, 27348-27357.
8. Colletti, L.M., Green, M., Burdick, M.D., Kunkel, S.L. & Strieter, R.M. (1998) Proliferative effects of CXC chemokines in rat hepatocytes in vitro and in vivo. Shock 10, 248-257.
9. Driscoll, K.E., Hassenbein, D.G., Howard, B.W., Isfort, R.J., Cody, D., Tindal, M.H., Suchanek, M. & Carter, J.M. (1995) Cloning, expression, and functional characterization of rat MIP-2: a neutrophil chemoattractant and epithelial cell mitogen. J. Leukoc. Biol. 58, 359-364.
10. 2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J. Exp. Med. 167, 1364-1376.
11. Proost, P., De Wolf-Peeters, C., Conings, R., Opdenakker, G., Billiau, A. & Van Damme, J. (1993) Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J. Immunol. 150, 1000-1010.
12. Smith, J.B. & Herschman, H.R. (1995) Glucocorticoid-attenuated response genes encode intercellular mediators, including a new C-X-C chemokine. J. Biol. Chem. 270, 16756-16765.
13. Wuyts, A., Haelens, A., Proost, P., Lenaerts, J.-P., Conings, R., Opdenakker, G. & Van Damme, J. (1996) Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2. J. Immunol. 157, 1736-1743.
14. Luster, A.D. (1998) Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338, 436-445.
15. Maione, T.E., Gray, G.S., Petro, J., Hunt, A.J., Donner, A.L., Bauer, S.I., Carson, H.F. & Sharpe, R.J. (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247, 77-79.
16. Ben-Baruch, A., Bengali, K., Tani, K., Xu, L., Oppenheim, J.J. & Wang, J.M. (1997) IL-8 and NAP-2 differ in their capacities to bind and chemoattract 293 cells transfected with either IL-8 receptor type A or type B. Cytokine 9, 37-45.
17. Wolf, M., Delgado, M.B., Jones, S.A., Dewald, B., Clark-Lewis, I. & Baggiolini, M. (1998) Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2. Eur. J. Immunol. 28, 164-170.
18. Wuyts, A., Proost, P., Lenaerts, J.P., Ben-Baruch, A., Van Damme, J. & Wang, J.M. (1998) Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78. Eur. J. Biochem. 255, 67-73.
19. Masure, S., Proost, P., Van Damme, J. & Opdenakker, G. (1991) Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. Eur. J. Biochem. 198, 391-398.
20. Peveri, P., Walz, A., Dewald, B. & Baggiolini, M. (1988) A novel neutrophil-activating factor produced by human mononuclear phagocytes. J. Exp. Med. 167, 1547-1559.
21. Carveth, H.J., Bohnsack, J.F., McIntyre, T.M., Baggiolini, M., Prescott, S.M. & Zimmerman, G.A. (1989) Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. Biochem. Biophys. Res. Commun. 162, 387-393.
22. Detmers, P.A., Lo, S.K., Olsen-Egbert, E., Walz, A., Baggiolini, M. & Cohn, Z.A. (1990) Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J. Exp. Med. 171, 1155-1162.
23. Peppin, G.J. & Weiss, S.J. (1986) Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc. Natl. Acad. Sci. USA 83, 4322-4326.
24. Ogata, Y., Enghild, J.J. & Nagase, H. (1992) Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J. Biol. Chem. 267, 3581-3584.
25. Moran, A., Iniesta, P., de Juan, C., Gonzalez-Quevedo, R., Sanchez-Pernaute, A., Diaz-Rubio, E., Cajal, S., Torres, A., Balibrea, J.L. & Benito, M. (2002) Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors. Cancer Res. 62, 3855-3860.
26. Hua, J. & Muschel, R.J. (1996) Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res. 56, 5279-5284.
27. Kobayashi, Y., Matsumoto, M., Kotani, M. & Makino, T. (1999) Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. J. Immunol. 163, 5989-5993.
28. Lane, W.J., Dias, S., Hattori, K., Heissig, B., Choy, M., Rabbany, S.Y., Wood, J., Moore, M.A. & Rafii, S. (2000) Stromal-derived factor 1-induced megakaryocyte migration and plalelet production is dependent on matrix metalloproteinases. Blood 96, 4152-4159.
29. D'Haese, A., Wuyts, A., Dillen, C., Dubois, B., Billiau, A., Heremans, H., Van Damme, J., Arnold, B. & Opdenakker, G. (2000) In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse. J. Interferon Cytokine Res. 20, 667-674.
30. Van den Steen, P.E., Proost, P., Grillet, B., Brand, D.D., Kang, A.H., Van Damme, J. & Opdenakker, G. (2002) Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J. 16, 379-389.
31. Fernandez-Patron, C., Zouki, C., Whittal, R., Chan, J.S., Davidge, S.T. & Filep, J.G. (2001) Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1-32]. FASEB J. 15, 2230-2240.
32. Van Coillie, E., Proost, P., Van Aelst, I., Struyf, S., Polfliet, M., De Meester, I., Harvey, D.J., Van Damme, J. & Opdenakker, G. (1998) Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. Biochemistry 37, 12672-12680.
33. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
34. 2-terminal heterogeneity. Functional comparison of different natural isoforms. Eur. J. Biochem. 260, 421-429.
35. McQuibban, G.A., Butler, G.S., Gong, J.H., Bendall, L., Power, C., Clark-Lewis, I. & Overall, C.M. (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276, 43503-43508.
36. Smith, J.B., Rovai, L.E. & Herschman, H.R. (1997) Sequence similarities of a subgroup of CXC chemokines related to murine LIX: implications for the interpretation of evolutionary relationships among chemokines. J. Leukoc. Biol. 62, 598-603.
37. Nufer, O., Corbett, M. & Walz, A. (1999) Amino-terminal processing of chemokine ENA-78 regulates biological activity. Biochemistry 38, 636-442.
38. 2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency. J. Immunol. 163, 6155-6163.
39. McQuibban, G.A., Gong, J.H., Wong, J.P., Wallace, J.L., Clark-Lewis, I. & Overall, C.M. (2002) Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100, 1160-1167.
40. Padrines, M., Wolf M., Walz, A. & Baggiolini, M. (1994) Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett. 352, 231-235.
41. Brandt, E., Petersen, F. & Flad, H.D. (1992) Recombinant tumor necrosis factor-α potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels. J. Immunol. 149, 1356-1364.
42. Proost, P., De Meester, I., Schols, D., Struyf, S., Lambeir, A.M., Wuyts, A., Opdenakker, G., De Clercq, E., Scharpé, S. & Van Damme, J. (1998) Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J. Biol. Chem. 273, 7222-7227.
43. Oravecz, T., Pall, M., Roderiquez, G., Gorrell, M.D., Ditto, M., Nguyen, N.Y., Boykins, R., Unsworth, E. & Norcross, M.A. (1997) Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186, 1865-1872.
44. De Meester, I., Korom, S., Van Damme, J. & Scharpé, S. (1999) CD26, let it cut or cut it down. Immunol. Today 20, 367-375.
45. Proost, P., Menten, P., Struyf, S., Schutyser, E., De Meester, I. & Van Damme, J. (2000) Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78β into a most efficient monocyte attractant and CCR1 agonist. Blood 96, 1674-1680.
46. Proost, P., Schutyser, E., Menten, P., Struyf, S., Wuyts, A., Opdenakker, G., Detheux, M., Parmentier, M., Durinx, C., Lambeir, A.M., Neyts, J., Liekens, S., Maudgal, P.C., Billiau, A. & Van Damme, J. (2001) Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98, 3554-3561.
47. Jansen, P.M., Van Damme, J., Put, W., de Jong, I.W., Taylor, F.B.J. & Hack, C.E. (1995) Monocyte chemotactic protein 1 is released during lethal and sublethal bacteremia in baboons. J. Infect. Dis. 171, 1640-1642.
48. Paemen, L., Jansen, P.M., Proost, P., Van Damme, J., Opdenakker, G., Hack, E. & Taylor, F.B. (1997) Induction of gelatinase B and MCP-2 in baboons during sublethal and lethal bacteraemia. Cytokine 9, 412-415.
49. Halloran, M.M., Woods, J.M., Strieter, R.M., Szekanecz, Z., Volin, M.V., Hosaka, S., Haines, G.K., Kunkel, S.L., Burdick, M.D., Walz, A. & Koch, A.E. (1999) The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis. J. Immunol. 162, 7492-7500.
50. Bergers, G., Brekken, R., McMahon, G., Vu, T.H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z. & Hanahan, D. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744.
51. Keane, M.P., Arenberg, D.A., Lynch, J.P., Whyte, R.I., Iannettoni, M.D., Burdick, M.D., Wilke, C.A., Morris, S.B., Glass, M.C., DiGiovine, B., Kunkel, S.L. & Strieter, R.M. (1997) The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J. Immunol. 159, 1437-1443.
52. Arenberg, D.A., Keane, M.P., DiGiovine, B., Kunkel, S.L., Morris, S.B., Xue, Y.Y., Burdick, M.D., Glass, M.C., Iannettoni, M.D. & Strieter, R.M. (1998) Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J. Clin. Invest. 102, 465-472.
53. Koch, A.E., Volin, M.V., Woods, J.M., Kunkel, S.L., Connors, M.A., Harlow, L.A., Woodruff, D.C., Burdick, M.D. & Strieter, R.M. (2001) Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint. Arthritis Rheum. 44, 31-40.
54. Opdenakker, G. & Van Damme, J. (1992) Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. Cytokine. 4, 251-258.
55. Coussens, L.M., Tinkle, C.L., Hanahan, D. & Werb, Z. (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481-490.
56. Van Coillie, E., Van Aelst, I., Wuyts, A., Vercauteren, R., Devos, R., De Wolf-Peeters, C., Van Damme, J. & Opdenakker, G. (2001) Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle. Am. J. Pathol. 159, 1405-1414.
57. Schteingart, D.E., Giordano, T.J., Benitez, R.S., Burdick, M.D., Starkman, M.N., Arenberg, D.A. & Strieter, R.M. (2001) Over-expression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome. J. Clin. Endocrinol. Metab. 86, 3968-3974.